Kindstar Globalgene Technology, Inc. disclosed that it repurchased 21,500 ordinary shares on 15 September 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were acquired at prices ranging from HKD 0.92 to HKD 0.93, resulting in a volume-weighted average cost of HKD 0.9253 per share and a total consideration of HKD 19,893.95.

Following the transaction, the company’s issued share capital (excluding treasury shares) decreased marginally by 0.00208 % to 1.03 billion shares, while treasury shares increased to 9.12 million. The total number of issued shares remained unchanged at 1.04 billion.

The repurchase formed part of the mandate approved on 05 June 2026, which authorises the buyback of up to 103.43 million shares. Cumulative repurchases under this mandate now stand at 2.06 million shares, equivalent to 0.20 % of the issued share base at the time the mandate was granted.

Under Hong Kong listing rules, Kindstar Global is subject to a 30-day moratorium—running through 15 October 2026—on issuing new shares or disposing of treasury shares following this repurchase.